Inflammatory response in on- versus off-pump myocardial revascularization: Is ECC really the culprit?

Thoracic and Cardiovascular Surgeon

Volumn 55, Issue 8, 2007, Pages 473-480

  Börgermann, Jochen ^a   Scheubel, R J ^a   Simm, A ^a   Silber, R E ^a   Friedrich, I ^a  

^a MARTIN LUTHER UNIVERSITY HALLE WITTENBERG   (Germany)

Author keywords

Cardiopulmonary bypass; Coronary artery surgery; Off pump; Systemic inflammatory response

Indexed keywords

C REACTIVE PROTEIN; CD11 ANTIGEN; CD18 ANTIGEN; INTERCELLULAR ADHESION MOLECULE 1; LIPOPOLYSACCHARIDE BINDING PROTEIN; PROCALCITONIN; THROMBOCYTE ACTIVATING FACTOR; TUMOR NECROSIS FACTOR ALPHA;

ANGIOGENESIS; BLOOD CLOTTING; COMPLEMENT ACTIVATION; CORONARY ARTERY BYPASS SURGERY; CYTOKINE RELEASE; DISEASE COURSE; ENDOTHELIUM CELL; EXTRACORPOREAL CIRCULATION; HEART MUSCLE ISCHEMIA; HEART MUSCLE REPERFUSION; HEART SURGERY; HEREDITY; HUMAN; IMMUNOCOMPETENT CELL; INTERMETHOD COMPARISON; LEUKOCYTE ACTIVATION; OFF PUMP CORONARY SURGERY; OXIDATIVE STRESS; PRIORITY JOURNAL; REVASCULARIZATION; REVIEW; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME;

COMPLEMENT ACTIVATION; CORONARY ARTERY BYPASS, OFF-PUMP; CYTOKINES; EXTRACORPOREAL CIRCULATION; HUMANS; IMMUNITY, CELLULAR; INFLAMMATION; MYOCARDIAL ISCHEMIA; MYOCARDIAL REVASCULARIZATION; OXIDATIVE STRESS; RISK FACTORS;

EID: 38149076490     PISSN: 01716425     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2007-965631     Document Type: Review

References (91)

1. Hall RI, Smith MS, Rocker G. The systemic inflammatory response to cardiopulmonary bypass: pathophysiological, therapeutic, and pharmacological considerations. Anesth Analg 1997; 85: 766-782
2. Wan S, LeClerc JL, Vincent JL. Inflammatory response to cardiopulmonary bypass: mechanisms involved and possible therapeutic strategies. Chest 1997; 112: 676-692
3. Chenoweth DE, Cooper SW, Hugli TE et al. Complement activation during cardiopulmonary bypass: evidence for generation of C3a and C5a anaphylatoxins. N Engl J Med 1981; 304: 497-503
4. Bitkover CY, Hansson LO, Valen G et al. Effects of cardiac surgery on some clinically used inflammation markers and procalcitonin. Scand Cardiovasc J 2000; 34: 307-314
5. Fransen E, Maessen J, Dentener M et al. Systemic inflammation present in patients undergoing CABG without extracorporeal circulation. Chest 1998; 113: 1290-1295
6. Kirklin JK, Westaby S, Blackstone EH et al. Complement and the damaging effects of cardiopulmonary bypass. J Thorac Cardiovasc Surg 1983; 86: 845-857
7. Moore FD Jr, Warner KG, Assousa S et al. The effects of complement activation during cardiopulmonary bypass. Attenuation by hypothermia, heparin, and hemodilution. Ann Surg 1988; 208: 95-103
8. Seghaye MC, Duchateau J, Grabitz RG et al. Complement activation during cardiopulmonary bypass in infants and children. Relation to postoperative multiple system organ failure. J Thorac Cardiovasc Surg 1993; 106: 978-987
9. Ascione R, Lloyd CT, Underwood MJ et al. Inflammatory response after coronary revascularization with or without cardiopulmonary bypass. Ann Thorac Surg 2000; 69: 1198-1204
10. Johansson-Synnergren M, Nilsson F, Bengtsson A et al. Off-pump CABG reduces complement activation but does not significantly affect peripheral endothelial function: a prospective randomized study. Scand Cardiovasc J 2004; 38: 53-58
11. Wehlin L, Vedin J, Vaage J et al. Activation of complement and leukocyte receptors during on- and off pump coronary artery bypass surgery. Eur J Cardiothorac Surg 2004; 25: 35-42
12. Struber M, Cremer JT, Gohrbandt B et al. Human cytokine responses to coronary artery bypass grafting with and without cardiopulmonary bypass. Ann Thorac Surg 1999; 68: 1330-1335
13. Gu YJ, Mariani MA, Boonstra PW et al. Complement activation in coronary artery bypass grafting patients without cardiopulmonary by-pass: the role of tissue injury by surgical incision. Chest 1999; 116: 892-898
14. Dreyer WJ, Michael LH, Millman EE et al. Neutrophil activation and adhesion molecule expression in a canine model of open heart surgery with cardiopulmonary bypass. Cardiovasc Res 1995; 29: 775-781
15. Asimakopoulos G, Taylor KM. Effects of cardiopulmonary bypass on leukocyte and endothelial adhesion molecules. Ann Thorac Surg 1998; 66: 2135-2144
16. Gillinov AM, Bator JM, Zehr KJ et al. Neutrophil adhesion molecule expression during cardiopulmonary bypass with bubble and membrane oxygenators. Ann Thorac Surg 1993; 56: 847-853
17. Ilton MK, Langton PE, Taylor ML et al. Differential expression of neutrophil adhesion molecules during coronary artery surgery with cardiopulmonary bypass. J Thorac Cardiovasc Surg 1999; 118: 930-937
18. Rinder CS, Bonan JL, Rinder HM et al. Cardiopulmonary bypass induces leukocyte-platelet adhesion. Blood 1992; 79: 1201-1205
19. Gillinov AM, Redmond JM, Winkelstein JA et al. Complement and neutrophil activation during cardiopulmonary bypass: a study in the complement-deficient dog. Ann Thorac Surg 1994; 57: 345-352
20. Gillinov AM, Redmond JM, Zehr KJ et al. Inhibition of neutrophil adhesion during cardiopulmonary bypass. Ann Thorac Surg 1994; 57: 126-133
21. Dreyer WJ, Michael LH, Millman EE et al. Neutrophil sequestration and pulmonary dysfunction in a canine model of open heart surgery with cardiopulmonary bypass. Evidence for a CD18-dependent mechanism. Circulation 1995; 92: 2276-2283
22. Kukielka GL, Youker KA, Hawkins HK et al. Regulation of ICAM-1 and IL-6 in myocardial ischemia: effect of reperfusion. Ann NY Acad Sci 1994; 723: 258-270
23. Youker KA, Hawkins HK, Kukielka GL et al. Molecular evidence for induction of intracellular adhesion molecule-1 in the viable border zone associated with ischemia-reperfusion injury of the dog heart. Circulation 1994; 89: 2736-2746
24. Brasil LA, Gomes WJ, Salomao R et al. Inflammatory response after myocardial revascularization with or without cardiopulmonary bypass. Ann Thorac Surg 1998; 66: 56-59
25. Diegeler A, Tarnok A, Rauch T et al. Changes of leukocyte subsets in coronary artery bypass surgery: cardiopulmonary bypass versus 'off-pump' techniques. Thorac Cardiovasc Surg 1998; 46: 327-332
26. Matata BM, Sosnowski AW, Galinanes M. Off-pump bypass graft operation significantly reduces oxidative stress and inflammation. Ann Thorac Surg 2000; 69: 785-791
27. Gu YJ, Mariani MA, van Oeveren W et al. Reduction of the inflammatory response in patients undergoing minimally invasive coronary artery bypass grafting. Ann Thorac Surg 1998; 65: 420-424
28. Al-Ruzzeh S, Hoare G, Marczin N et al. Off-pump coronary artery bypass surgery is associated with reduced neutrophil activation as measured by the expression of CD11b: a prospective randomized study. Heart Surg Forum 2003; 6: 89-93
29. Boldt J, Osmer C, Linke LC et al. Circulating adhesion molecules in pediatric cardiac surgery. Anesth Analg 1995; 81: 1129-1135
30. Menasche P, Peynet J, Lariviere J et al. Does normothermia during cardiopulmonary bypass increase neutrophil-endothelium interactions? Circulation 1994; 90: II275-II279
31. Wildhirt SM, Schulze C, Schulz C et al. Reduction of systemic and cardiac adhesion molecule expression after off-pump versus conventional coronary artery bypass grafting. Shock 2001; 16 (Suppl 1): 55-59
32. Wildhirt SM, Schulze C, Conrad N et al. Reduced myocardial cellular damage and lipid peroxidation in off-pump versus conventional coronary artery bypass grafting. Eur J Med Res 2000; 5: 222-228
33. Markewitz A, Lante W, Franke A et al. Alterations of cell-mediated immunity following cardiac operations: clinical implications and open questions. Shock 2001; 16 (Suppl 1): 10-15
34. Nguyen DM, Mulder DS, Shennib H. Effect of cardiopulmonary bypass on circulating lymphocyte function. Ann Thorac Surg 1992; 53: 611-616
35. Naldini A, Borrelli E, Cesari S et al. In vitro cytokine production and T-cell proliferation in patients undergoing cardiopulmonary by-pass. Cytokine 1995; 7: 165-170
36. Markewitz A, Faist E, Lang S et al. Regulation of acute phase response after cardiopulmonary bypass by immunomodulation. Ann Thorac Surg 1993; 55: 389-394
37. Börgermann J, Friedrich I, Flohé S et al. Tumor necrosis factor-alpha production in whole blood after cardiopulmonary bypass: downregulation caused by circulating cytokine-inhibitory activities. J Thorac Cardiovasc Surg 2002; 124: 608-617
38. Kleinschmidt S, Wanner GA, Bussmann D et al. Proinflammatory cytokine gene expression in whole blood from patients undergoing coronary artery bypass surgery and its modulation by pentoxifylline. Shock 1998; 9: 12-20
39. Hiesmayr MJ, Spittler A, Lassnigg A et al. Alterations in the number of circulating leucocytes, phenotype of monocyte and cytokine production in patients undergoing cardiothoracic surgery. Clin Exp Immunol 1999; 115: 315-323
40. Rinder CS, Mathew JP, Rinder HM et al. Lymphocyte and monocyte subset changes during cardiopulmonary bypass: effects of aging and gender. J Lab Clin Med 1997; 129: 592-602
41. Flohé S, Börgermann J, Dominguez FE et al. Influence of granulocyte-macrophage colony-stimulating factor (GM-CSF) on whole blood endotoxin responsiveness following trauma, cardiopulmonary bypass, and severe sepsis. Shock 1999; 12: 17-24
42. Dehoux MS, Hernot S, Asehnoune K et al. Cardiopulmonary bypass decreases cytokine production in lipopolysaccharide-stimulated whole blood cells: roles of interleukin-10 and the extracorporeal circuit. Crit Care Med 2000; 28: 1721-1727
43. Strohmeyer JC, Blume C, Meisel C et al. Standardized immune monitoring for the prediction of infections after cardiopulmonary bypass surgery in risk patients. Cytometry 2003; 53B: 54-62
44. Carmeliet P. Mechanisms of angiogenesis and arteriogenesis. Nat Med 2000; 6: 389-395
45. Nissen NN, Polverini PJ, Koch AE et al. Vascular endothelial growth factor mediates angiogenic activity during the proliferative phase of wound healing. Am J Pathol 1998; 152: 1445-1452
46. Neufeld G, Cohen T, Gengrinovitch S et al. Vascular endothelial growth factor (VEGF) and its receptors. Faseb J 1999; 13: 9-22
47. Asahara T, Masuda H, Takahashi T et al. Bone marrow origin of endothelial progenitor cells responsible for postnatal vasculogenesis in physiological and pathological neovascularization. Circ Res 1999; 85: 221-228
48. Gill M, Dias S, Hattori K et al. Vascular trauma induces rapid but transient mobilization of VEGFR2(+)AC133(+) endothelial precursor cells. Circ Res 2001; 88: 167-174
49. Sinnaeve P, Chiche JD, Nong Z et al. Soluble guanylate cyclase alpha(1) and beta(1) gene transfer increases NO responsiveness and reduces neointima formation after balloon injury in rats via antiproliferative and antimigratory effects. Circ Res 2001; 88: 103-109
50. Burton PB, Owen VJ, Hafizi S et al. Vascular endothelial growth factor release following coronary artery bypass surgery: extracorporeal circulation versus 'beating heart' surgery. Eur Heart J 2000; 21: 1708-1713
51. Scheubel RJ, Zorn H, Silber RE et al. Age-dependent depression in circulating endothelial progenitor cells in patients undergoing coronary artery bypass grafting. J Am Coll Cardiol 2003; 42: 2073-2080
52. Diegeler A, Doll N, Rauch T et al. Humoral immune response during coronary artery bypass grafting: a comparison of limited approach, "off-pump" technique, and conventional cardiopulmonary bypass. Circulation 2000; 102: III95-III100
53. Schulze C, Conrad N, Schutz A et al. Reduced expression of systemic proinflammatory cytokines after off-pump versus conventional coronary artery bypass grafting. Thorac Cardiovasc Surg 2000; 48: 364-369
54. Wan S, DeSmet JM, Barvais L et al. Myocardium is a major source of proinflammatory cytokines in patients undergoing cardiopulmonary bypass. J Thorac Cardiovasc Surg 1996; 112: 806-811
55. Wan S, Izzat MB, Lee TW et al. Avoiding cardiopulmonary bypass in multivessel CABG reduces cytokine response and myocardial injury. Ann Thorac Surg 1999; 68: 52-56
56. Gulielmos V, Menschikowski M, Dill H et al. Interleukin-1, interleukin-6 and myocardial enzyme response after coronary artery bypass grafting - a prospective randomized comparison of the conventional and three minimally invasive surgical techniques. Eur J Cardiothorac Surg 2000; 18: 594-601
57. Kukielka GL, Smith CW, LaRosa GJ et al. Interleukin-8 gene induction in the myocardium after ischemia and reperfusion in vivo. J Clin Invest 1995; 95: 89-103
58. Burns SA, Newburger JW, Xiao M et al. Induction of interleukin-8 messenger RNA in heart and skeletal muscle during pediatric cardiopulmonary bypass. Circulation 1995; 92: II315-II321
59. Kawamura T, Wakusawa R, Okada K et al. Elevation of cytokines during open heart surgery with cardiopulmonary bypass: participation of interleukin 8 and 6 in reperfusion injury. Can J Anaesth 1993; 40: 1016-1021
60. Randow F, Syrbe U, Meisel C et al. Mechanism of endotoxin desensitization: involvement of interleukin 10 and transforming growth factor beta. J Exp Med 1995; 181: 1887-1892
61. de Waal Malefyt R, Abrams J, Bennett B et al. Interleukin 10(IL-10) inhibits cytokine synthesis by human monocytes: an autoregulatory role of IL-10 produced by monocytes. J Exp Med 1991; 174: 1209-1220
62. Yang Z, Zingarelli B, Szabo C. Crucial role of endogenous interleukin-10 production in myocardial ischemia/reperfusion injury. Circulation 2000; 101: 1019-1026
63. Seghaye M, Duchateau J, Bruniaux J et al. Interleukin-10 release related to cardiopulmonary bypass in infants undergoing cardiac operations. J Thorac Cardiovasc Surg 1996; 111: 545-553
64. Wan S, LeClerc JL, Schmartz D et al. Hepatic release of interleukin-10 during cardiopulmonary bypass in steroid-pretreated patients. Am Heart J 1997; 133: 335-339
65. Wan S, LeClerc JL, Vincent JL. Cytokine responses to cardiopulmonary bypass: lessons learned from cardiac transplantation. Ann Thorac Surg 1997; 63: 269-276
66. Wan S, Marchant A, DeSmet JM et al. Human cytokine responses to cardiac transplantation and coronary artery bypass grafting. J Thorac Cardiovasc Surg 1996; 111: 469-477
67. Tomic V, Russwurm S, Moller E et al. Transcriptomic and proteomic patterns of systemic inflammation in on-pump and off-pump coronary artery bypass grafting. Circulation 2005; 112: 2912-2920
68. Wan IY, Arifi AA, Wan S et al. Beating heart revascularization with or without cardiopulmonary bypass: evaluation of inflammatory response in a prospective randomized study. J Thorac Cardiovasc Surg 2004; 127: 1624-1631
69. Rastan AJ, Bittner HB, Gummert JF et al. On-pump beating heart versus off-pump coronary artery bypass surgery-evidence of pump-induced myocardial injury. Eur J Cardiothorac Surg 2005; 27: 1057-1064
70. Stuber F, Petersen M, Bokelmann F et al. A genomic polymorphism within the tumor necrosis factor locus influences plasma tumor necrosis factor-alpha concentrations and outcome of patients with severe sepsis. Crit Care Med 1996; 24: 381-384
71. Majetschak M, Flohé S, Obertacke U et al. Relation of a TNF gene polymorphism to severe sepsis in trauma patients. Ann Surg 1999; 230: 207-214
72. Flach R, Majetschak M, Heukamp T et al. Relation of ex vivo stimulated blood cytokine synthesis to post-traumatic sepsis. Cytokine 1999; 11: 173-178
73. Schroeder S, Borger N, Wrigge H et al. A tumor necrosis factor gene polymorphism influences the inflammatory response after cardiac operation. Ann Thorac Surg 2003; 75: 534-537
74. Tomasdottir H, Hjartarson H, Ricksten A et al. Tumor necrosis factor gene polymorphism is associated with enhanced systemic inflammatory response and increased cardiopulmonary morbidity after cardiac surgery. Anesth Analg 2003; 97: 944-949
75. Brull DJ, Montgomery HE, Sanders J et al. Interleukin-6 gene - 174 g>c and -572 g>c promoter polymorphisms are strong predictors of plasma interleukin-6 levels after coronary artery bypass surgery. Arterioscler Thromb Vasc Biol 2001; 21: 1458-1463
76. Gaudino M, Andreotti F, Zamparelli R et al. The - 174 G/C interleukin-6 polymorphism influences postoperative interleukin-6 levels and post-operative atrial fibrillation. Is atrial fibrillation an inflammatory complication? Circulation 2003; 108 (Suppl 1): II195-II199
77. Galley HF, Lowe PR, Carmichael RL et al. Genotype and interleukin-10 responses after cardiopulmonary bypass. Br J Anaesth 2003; 91: 424-426
78. Ryan T, Balding J, McGovern EM et al. Lactic acidosis after cardiac surgery is associated with polymorphisms in tumor necrosis factor and interleukin 10 genes. Ann Thorac Surg 2002; 73: 1905-1909
79. Philip I, Plantefeve G, Vuillaumier-Barrot S et al. G894T polymorphism in the endothelial nitric oxide synthase gene is associated with an enhanced vascular responsiveness to phenylephrine. Circulation 1999; 99: 3096-3098
80. Lefer DJ, Granger DN. Oxidative stress and cardiac disease. Am J Med 2000; 109: 315-323
81. Cavarocchi NC, England MD, Schaff HV et al. Oxygen free radical generation during cardiopulmonary bypass: correlation with complement activation. Circulation 1986; 74: III130-III133
82. Cavalca V, Sisillo E, Veglia F et al. Isoprostanes and oxidative stress in off-pump and on-pump coronary bypass surgery. Ann Thorac Surg 2006; 81: 562-567
83. Gerritsen WB, van Boven WJ, Driessen AH et al. Off-pump versus on-pump coronary artery bypass grafting: oxidative stress and renal function. Eur J Cardiothorac Surg 2001; 20: 923-929
84. Sahlman A, Ahonen J, Nemlander A et al. Myocardial metabolism on off-pump surgery; a randomized study of 50 cases. Scand Cardiovasc J 2003; 37: 211-215
85. Butler J, Rocker GM, Westaby S. Inflammatory response to cardiopulmonary bypass. Ann Thorac Surg 1993; 55: 552-559
86. Edmunds LH Jr. Blood-surface interactions during cardiopulmonary bypass. J Card Surg 1993; 8: 404-410
87. Angelini GD, Taylor FC, Reeves BC et al. Early and midterm outcome after off-pump and on-pump surgery in Beating Heart Against Cardioplegic Arrest Studies (BHACAS 1 and 2): a pooled analysis of two randomised controlled trials. Lancet 2002; 359: 1194-1199
88. van Dijk D, Nierich AP, Jansen EW et al. Early outcome after off-pump versus on-pump coronary bypass surgery: results from a randomized study. Circulation 2001; 104: 1761-1766
89. Mariani MA, Gu YJ, Boonstra PW et al. Procoagulant activity after off-pump coronary operation: is the current anticoagulation adequate? Ann Thorac Surg 1999; 67: 1370-1375
90. Casati V, Gerli C, Franco A et al. Activation of coagulation and fibrinolysis during coronary surgery: on-pump versus off-pump techniques. Anesthesiology 2001; 95: 1103-1109
91. Mangano DT. Aspirin and mortality from coronary bypass surgery. N Engl J Med 2002; 347: 1309-1317